RYCAX (RYCAX) Stock Price & Analysis
RYCAX (RYCAX) fell 0.95% to USD 95.83 as of September 9, 2026 at 02:22 UTC, according to Nexqual real-time market data.
RYCAX last closed at USD 95.83; the session ranged USD 95.83–95.83 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 87.23–117.24 (NAS). Source: Nexqual, September 9, 2026 at 02:22 UTC.
Key Statistics (as of September 9, 2026 at 02:22 UTC)
| Price | USD 95.83 |
|---|---|
| Change | ▼ 0.95% (down) |
| Previous Close | USD 95.83 |
| Open | USD 95.83 |
| Day Range | USD 95.83 – 95.83 |
| 52-Week Range | USD 87.23 – 117.24 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (RYCAX)
Nexqual's technical model rates RYCAX "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 02:22 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 39.46 (neutral) |
| vs SMA50 | Below (USD 97.66) |
| MACD | -0.11 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RYKAX | Rydex Series Fds, Banking Fund | USD 116.55 | ▼ 1.26% |
| RYHAX | Rydex Series Fds, Health Care F | USD 128.57 | ▼ 3.11% |
| RYBAX | Rydex Series Fds, Basic Materia | USD 89.3 | ▼ 1.22% |
| RYEAX | Rydex Series Fds, Energy Fund H | USD 325.67 | ▲ 0.57% |
| RYOAX | Rydex Series Fds, Biotechnology | USD 72.81 | ▼ 2.86% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 02:22 UTC. This page is informational and not investment advice.